Please assess the completion status of the following clinical trial:

Trial Title: Effects of 3 Day Preoperative Immunonutrition in Well-nourished Patients With Gastrointestinal (GI) Cancer Undergoing Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with GI cancer (stomach, pancreas, small and large bowel and rectum) histologically proven~* Well nourished patients as defined by a total score of \<3 on the nutritional screening tool NRS-2002 (46) (Appendix III)~* Patients who are \>= 18 years of age;~* Patients who have signed a written Informed Consent (Appendix I) prior to admission to the study;~* Patients who have an ECOG performance status of 0, 1 or 2 (Appendix II).~* Patients able to orally consume 750 mL or more of liquid a day prior to surgery~Exclusion Criteria:~* Patients who have co-morbid conditions, uncontrolled metabolic conditions or psychiatric conditions that might make tolerance or evaluation of the feeding formula difficult;~* Patients who are pregnant;~* Patients with cardiac failure as defined by the Goldman classification class\>3~* Patients with respiratory failure (FEV\<0.8l/sec)~* Patients with renal failure (Cr \>= 3mg/dl or dialysis patients)~* Patients with hepatic dysfunction (Child \>A)~* Patients suffering from an intestinal obstruction or ileum~* Patients with an Hb level of \<=8 g/dL experiencing gastrointestinal hemorrhaging~* Patients with HIV, HCV, HBV~* Patients requiring immunosuppression treatments~* Patients undergoing emergency surgery~* Other patients determined by a study investigator to be inappropriate for enrolment in this study

- Gender: None
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Nutritional product (Type: ACTIVE_COMPARATOR): Oral nutritional supplement containing immuno nutrients
- Isocaloric control (Type: PLACEBO_COMPARATOR): Isocaloric and isonitrogenous control without immuno nutrients

Based on this trial design, predict the completion outcome and termination type (if applicable).